TAFAZZIN and Barth syndrome: Although there is currently no cure for Barth syndrome, Tafazzin replacement therapy using adeno-associated virus (AAV) vector shows promising results in Tafazzin knockdown mice, including improved mitochondrial structure, mitochondrial respiration and heart function (Suzuki-Hatano et al., 2019).